Article thumbnail

Unexpected Diversity of Cellular Immune Responses against Nef and Vif in HIV-1-Infected Patients Who Spontaneously Control Viral Replication

By Leandro F. Tarosso, Mariana M. Sauer, Sabri Sanabani, Maria Teresa Giret, Helena I. Tomiyama, John Sidney, Shari M. Piaskowski, Ricardo S. Diaz, Ester C. Sabino, Alessandro Sette, Jorge Kalil-Filho, David I. Watkins and Esper G. Kallas
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2896403
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2006). A Community Resource Benchmarking Predictions Of Peptide Binding To MHCI Molecules.
  2. (2004). Analysis Of Antigen-Specific T-Cell Responses With Synthetic Peptides–What Kind Of Peptide For Which Purpose?
  3. (2000). Analysis Of CD8 T Cell Reactivity To Cytomegalovirus Using Protein-Spanning Pools Of Overlapping Pentadecapeptides.
  4. (2001). Analysis Of Total Human Immunodeficiency Virus (HIV)-Specific CD4(+)A n d CD8(+) T-Cell Responses: Relationship To Viral Load In Untreated HIV Infection.
  5. (2006). Approximate Likelihood-Ratio Test For Branches: A Fast, Accurate, And Powerful Alternative.
  6. (2000). Characterization Of Human Immunodeficiency Virus Type 1 Vif Gene In Long-Term Asymptomatic Individuals.
  7. (2000). Characterization Of Three Nef-Defective Human Immunodeficiency Virus Type 1 Strains Associated With Long-Term Nonprogression. Australian LongTerm Nonprogressor Study Group.
  8. (2003). Comparison Of Overlapping Peptide Sets For Detection Of Antiviral
  9. (1995). Conservation Of An Intact Human Immunodeficiency Virus Type 1 Vif Gene In Vitro And In Vivo.
  10. (2005). CrossReactivity Of Anti-HIV-1 T Cell Immune Responses Among The Major HIV-1 Clades In HIV-1-Positive Individuals From 4 Continents.
  11. (1996). Cytotoxic T Lymphocytes In Asymptomatic Long-Term Nonprogressing HIV-1 Infection. Breadth And Specificity Of The Response And Relation To In Vivo Viral Quasispecies In A Person With Prolonged Infection And Low Viral Load.
  12. (2007). Elite Control Of HIV Infection: Implications For Vaccines And Treatment.
  13. (2003). Enhanced Detection Of Human Immunodeficiency Virus Type 1-Specific TCell Responses To Highly Variable Regions By Using Peptides Based On Autologous Virus Sequences.
  14. (2004). Establishment Of The Serologic Testing Algorithm For Recent Human Immunodeficiency Virus (HIV) Seroconversion (STARHS) Strategy In The City Of Sao Paulo,
  15. (2006). FullLength Genome Analysis Of Human Immunodeficiency Virus Type 1 Subtype C In Brazil.
  16. (2008). Genetic And Immunologic Heterogeneity Among Persons Who Control HIV Infection In The Absence Of Therapy.
  17. (2008). Genetic Characterization Of Human Immunodeficiency Virus Type 1 In Elite Controllers: Lack Of Gross Genetic Defects Or Common Amino Acid Changes.
  18. (1998). Grossly Defective Nef Gene Sequences In A Human Immunodeficiency Virus Type 1-Seropositive Long-Term Nonprogressor.
  19. (2007). HIV Controllers Exhibit Potent CD8 T Cell Capacity To Suppress HIV Infection Ex Vivo And Peculiar Cytotoxic T Lymphocyte Activation Phenotype.
  20. (2005). HIV Controllers: A Homogeneous Group Of HIV-1-Infected Patients With Spontaneous Control Of Viral Replication.
  21. (2007). HIV Controllers: How Do They Tame The Virus? Trends Immunol
  22. (2002). HIV-Specific CD8+ T Cell Proliferation Is Coupled To Perforin Expression And Is Maintained In Nonprogressors.
  23. (2000). HLA B*5701 Is Highly Associated With Restriction Of Virus Replication In A Subgroup Of HIV-Infected Long Term Nonprogressors.
  24. (2008). HLA Class IRestricted T-Cell Responses May Contribute To The Control Of Human Immunodeficiency Virus Infection, But Such Responses Are Not Always Necessary For Long-Term Virus Control.
  25. (2007). Human Immunodeficiency Virus Controllers: Mechanisms Of Durable Virus Control In The Absence Of Antiretroviral Therapy.
  26. (2002). Identification Of A Host Protein Essential For Assembly Of Immature HIV-1 Capsids.
  27. (2008). Immune Epitope Database Analysis Resource (IEDB-AR).
  28. (2004). Influence Of Primate Lentiviral Vif And Proteasome Inhibitors On Human Immunodeficiency Virus Type 1 Virion Packaging Of APOBEC3G.
  29. (2005). Los Alamos: Theoretical Biology & Biophysics.
  30. (2008). Lytic Granule Loading Of CD8+ T Cells Is Required For HIV-Infected Cell Elimination Associated With Immune Control.
  31. (2006). Maintenance Of Viral Suppression In HIV-1-Infected HLA-B*57+ Elite Suppressors Despite CTL Escape Mutations.
  32. (1999). Maternal Levels Of Plasma Human Immunodeficiency Virus Type 1 RNA And The Risk Of Perinatal Transmission. Women And Infants Transmission Study Group.
  33. (1992). Role Of Vif In Replication Of Human Immunodeficiency Virus Type 1 In CD4+ T Lymphocytes.
  34. (1995). Studies In Subjects With Long-Term Nonprogressive Human Immunodeficiency Virus Infection.
  35. (2007). Subdominant CD8+ T-Cell Responses Are Involved In Durable Control Of AIDS Virus Replication.
  36. (1994). Temporal Association Of Cellular Immune Responses With The Initial Control Of Viremia In Primary Human Immunodeficiency Virus Type 1 Syndrome.
  37. (1997). The CLUSTAL_X Windows Interface: Flexible Strategies For Multiple Sequence Alignment Aided By Quality Analysis Tools.
  38. (2006). The High-Frequency Major Histocompatibility Complex Class I Allele Mamu-B*17 Is Associated With Control Of Simian Immunodeficiency Virus Sivmac239 Replication.
  39. (2007). Understanding Prediction Systems For HLA-Binding Peptides And T-Cell Epitope Identification In:
  40. (2000). Unusual Polymorphisms In Human Immunodeficiency Virus Type 1 Associated With Nonprogressive Infection.
  41. (1996). VifNegative Human Immunodeficiency Virus Type 1 Persistently Replicates In Primary Macrophages, Producing Attenuated Progeny Virus.
  42. (1997). Vigorous HIV-1-Specific CD4+
  43. (1994). Virus-Specific CD8+ Cytotoxic T-Lymphocyte Activity Associated With Control Of Viremia In Primary Human Immunodeficiency Virus Type 1 Infection.
  44. (2003). Vpr R77Q Is Associated With Long-Term Nonprogressive HIV Infection And Impaired Induction Of Apoptosis.